logo
Plus   Neg
Share
Email

Stock Alert: Enlivex Soars On Positive Results From Its Covid-19 Drug

Shares of clinical-stage immunotherapy company, Enlivex Therapeutics Ltd. (ENLV) are surging nearly 70% Thursday morning after the company reported positive top-line results from the study of its Covid-19 drug candidate, Allocetra.

The investigator-initiated study of Allocetra included five Covid-19 patients- three in severe condition and two in critical condition. All five patients had complete recovery from their respective condition and were released from the hospital, following administration of Allocetra, Enlivex said

There were no reported severe adverse events relating to the administration of Allocetra in the patients, and the therapy was well-tolerated, the company noted.

The company plans to start phase IIb study of Allocetra in the fourth quarter of 2020.

Enlivex stock is currently trading at $10.07. It has traded in the range of $3.59- $27.28 in the last one year.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
A Brazilian volunteer, who participated in a clinical trial of the COVID-19 vaccine developed by AstraZeneca and Oxford University, has died, Brazilian health authority Anvisa said. Oxford university reportedly confirmed the plan to continue the trial after careful assessment that there have been no concerns about safety of the clinical trial. NASA's Osiris-Rex robotic spacecraft briefly touched down on near-Earth asteroid Bennu's surface on Tuesday to collect rock and dust samples that will be brought back to Earth in 2023. Bennu is currently more than 200 million miles, or 321 million kilometres, from Earth. Osiris-Rex launched from Cape Canaveral Air Force Station in Florida in September 2016. Amazon said Wednesday that free one-hour grocery pickup is now available to prime members at all U.S. Whole Foods Market locations. Previously, the prime members could pick up Whole Foods orders only at select stores.
Follow RTT